Enovis Corporation (ENOV) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Enovis Corporation (ENOV) closed at USD 18.57 on 2026-10-14, a change of -43.5 % over the past year, with a market capitalization of USD 1.12B.

Enovis Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Enovis Corporation key figures

Previous close

USD 18.57 (2026-10-14)

1-year change

-43.5 %

Market cap

USD 1.12B

Enterprise value

USD 2.47B

P/E ratio (trailing)

-1.03

P/E ratio (forward)

5.46

EPS (trailing)

-18.80

EPS (forward)

3.54

PEG ratio

3.45

Price to book

0.76

Revenue growth

3.2 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

4.86

Employees

7,802

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Enovis Corporation

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Lewisville, Texas.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Enovis Corporation and compare it with other stocks.